{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T22:38:50Z","timestamp":1705358330795},"reference-count":44,"publisher":"Medical Association of Nippon Medical School","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1272\/jnms.82.193","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T18:04:11Z","timestamp":1441130651000},"page":"193-201","source":"Crossref","is-referenced-by-count":5,"title":["A Case of Cryoglobulinemic Membranoproliferative Glomerulonephritis Induced by Hepatitis C Virus"],"prefix":"10.1272","volume":"82","author":[{"given":"Tomoyuki","family":"Otsuka","sequence":"first","affiliation":[{"name":"Department of Nephrology, Nippon Medical School Musashi Kosugi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinao","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nippon Medical School Musashi Kosugi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nippon Medical School Musashi Kosugi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Tsuruoka","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH: Hepatitis C and Renal Disease: An Update. Am J kidney Dis 2003; 42: 631-657.","DOI":"10.1016\/S0272-6386(03)00828-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kamar N, Izopet J, Alric L, Guilbeaud-Frugier C, Rostaing L: Hepatitis C virus-related kidney disease: an overview. Clin Nephrol 2008; 69: 149-160.","DOI":"10.5414\/CNP69149"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gumber SC, Chopra S: Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-620.","DOI":"10.7326\/0003-4819-123-8-199510150-00008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-470.","DOI":"10.1056\/NEJM199302183280703"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pucillo LP, Agnello V: Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: from viruslike particles in the cryoprecipitate to viral localization in paramesangial deposits, problematic investigations prone to artifacts. Curr Opin Nephrol Hypertens 1994; 3: 465-470.","DOI":"10.1097\/00041552-199407000-00014"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. D'Amico G, Fornasieri A: Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995; 25: 361-369.","DOI":"10.1016\/0272-6386(95)90095-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. McMurray RW, Elbourne K: Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997; 26: 689-701.","DOI":"10.1016\/S0049-0172(97)80005-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P: Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am J Kidney Dis 2013; 61: 623-637.","DOI":"10.1053\/j.ajkd.2012.08.040"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kamar N, Rostaing L, Alric L: Treatment of hepatitis C-virus-related glomerulonephritis. Kidney Int 2006; 69: 436-439.","DOI":"10.1038\/sj.ki.5000142"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Francesca Donato M, Banfi G, Cresseri D, Battista Fogazzi G, Martin P, Messa P, Fabrizi F: Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review. Int J Artif Organs 2013; 36: 367-372.","DOI":"10.5301\/ijao.5000199"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Siami GA, Siami FS, Ferguson P, Stone WJ, Zborowski M: Cryofiltration apheresis for treatment of cryoglobulinemia associated with hepatitis C. Asaio J 1995; 41: M315-318.","DOI":"10.1097\/00002480-199507000-00021"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Siami FS, Siami GA: A last resort modality using cryofiltration apheresis for the treatment of cold hemagglutinin disease in a Veterans Administration hospital. Ther Apher Dial 2004; 8: 398-403.","DOI":"10.1111\/j.1526-0968.2004.00182.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakajima H, Kaneko S, Takano T, Hoshino T, Sato Y, Kawase T, Tsukamoto Y: Analysis of protein removal properties during cryofiltration apheresis using the evaflux-5A plasma fractionator in a patient with hepatitis C virus-associated cryoglobulinemic glomerulonephritis. Ther Apher Dial 2014; 18: 258-264.","DOI":"10.1111\/1744-9987.12213"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Namba T, Shiba R, Yamamoto T, Hirai Y, Moriwaki T, Matsuda J, Kadoya H, Takeji M, Yamada Y, Yoshihara H, Yamauchi A: Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy. Clin Exp Nephrol 2010; 14: 372-376.","DOI":"10.1007\/s10157-010-0282-3"},{"key":"15","unstructured":"15. Garini G, Allegri L, Vaglio A, Buzio C: Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies. Ann Ital Med Int 2005; 20: 71-80."},{"key":"16","unstructured":"17. Takada S, Shimizu T, Hadano Y, Matsumoto K, Kataoka Y, Arima Y, Inoue T, Sorano S: Cryoglobulinemia (review). Mol Med Rep 2012; 6: 3-8."},{"key":"17","unstructured":"18. Retamozo S, Brito-Zeron P, Bosch X, Stone JH, Ramos-Casals M: Cryoglobulinemic disease. Oncology (Williston Park) 2013; 27: 1098-1105, 1110-1116."},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Dustin LB, Charles ED: Primary, post-primary and non-specific immunoglobulin M responses in HCV infection. Antivir Ther 2012; 17: 1449-1452.","DOI":"10.3851\/IMP2222"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20. Kondo Y, Shimosegawa T: Direct effects of hepatitis C virus on the lymphoid cells. World J Gastroenterol 2013; 19: 7889-7895.","DOI":"10.3748\/wjg.v19.i44.7889"},{"key":"20","unstructured":"21. Michaud M, Pourrat J: Cryofibrinogenemia. Journal of clinical rheumatology: J Clin Rheumatol 2013; 19: 142-148."},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Tsuboi N, Ichinose M, Kawamura T, Joh K, Utsunomiya Y, Hosoya T: Rapidly progressive cryoglobulinemic glomerulonephritis. Clin Exp Nephrol 2010; 14: 492-495.","DOI":"10.1007\/s10157-010-0301-4"},{"key":"22","unstructured":"23. Sumida K, Ubara Y, Hoshino J, Suwabe T, Nakanishi S, Hiramatsu R, Hasegawa E, Hayami N, Yamanouchi M, Sawa N, Takemoto F, Takaichi K, Oohashi K: Hepatitis C virus-related kidney disease: various histological patterns. Clin Nephrol 2010; 74: 446-456."},{"key":"23","unstructured":"24. Sabbatini A, Dolcher MP, Marchini B, Chimenti D, Moscato S, Pratesi F, Bombardieri S, Migliorini P: Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin Exp Rheumatol 1997; 15: 655-658."},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Morosetti M, Sciarra G, Meloni C, Palmieri G, Palombo G, Taccone Gallucci M, Casciani CU: Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern. Nephrol Dial Transplant 1996; 11: 532-534.","DOI":"10.1093\/oxfordjournals.ndt.a027324"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Gilli P, Stabellini N, Storari A, Gualandi G, Guerra G, Ghinelli F: Effect of human leukocyte alpha interferon on cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Nephrol Dial Transplant 1996; 11: 526-528.","DOI":"10.1093\/oxfordjournals.ndt.a027322"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27. Sarac E, Bastacky S, Johnson JP: Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection. Am J Kidney Dis 1997; 30: 113-115.","DOI":"10.1016\/S0272-6386(97)90572-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28. Sarrazin C, Hezode C, Zeuzem S, Pawlotsky JM: Antiviral strategies in hepatitis C virus infection. J Hepatol 2012; 56 (Suppl 1): S88-100.","DOI":"10.1016\/S0168-8278(12)60010-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Feng B, Eknoyan G, Guo ZS, Jadoul M, Rao HY, Zhang W, Wei L: Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis. Nephrol Dial Transplant 2012; 27: 640-646.","DOI":"10.1093\/ndt\/gfr236"},{"key":"29","unstructured":"30. Migliorini A, Angelotti ML, Mulay SR, Kulkarni OO, Demleitner J, Dietrich A, Sagrinati C, Ballerini L, Peired A, Shankland SJ, Liapis H, Romagnani P, Anders HJ: The antiviral cytokines IFN-alpha and IFN-beta modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am J Pathol 2013; 183: 431-440."},{"key":"30","doi-asserted-by":"crossref","unstructured":"31. Fabrizi F, Fogazzi GB, Cresseri D, Passerini P, Martin P, Donato MF, Rumi MG, Messa P: Antiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literature. Kidney Blood Press Res 2012; 35: 687-693.","DOI":"10.1159\/000345515"},{"key":"31","unstructured":"32. Gentile I, Buonomo AR, Zappulo E, Minei G, Morisco F, Borrelli F, Coppola N, Borgia G: Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. Ther Clin Risk Manag 2014; 10: 493-504."},{"key":"32","doi-asserted-by":"crossref","unstructured":"33. Poveda E, Wyles DL, Mena A, Pedreira JD, Castro-Iglesias A, Cachay E: Update on hepatitis C virus resistance to direct-acting antiviral agents. Antiviral Res 2014; 108c: 181-191.","DOI":"10.1016\/j.antiviral.2014.05.015"},{"key":"33","unstructured":"34. Degasperi E, Aghemo A: Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives. Hepat Med 2014; 6: 25-33."},{"key":"34","doi-asserted-by":"crossref","unstructured":"35. Markowitz GS, Nasr SH, Stokes MB, D'Agati VD: Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010; 5: 607-615.","DOI":"10.2215\/CJN.07311009"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36. Gluhovschi C, Gadalean F, Kaycsa A, Curescu M, Sporea I, Gluhovschi G, Petrica L, Velciov S, Bozdog G, Bob F, Vernic C, Cioca D: Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects? Immunopharmacol Immunotoxicol 2011; 33: 744-750.","DOI":"10.3109\/08923973.2010.551129"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37. Heim MH: Innate immunity and HCV. J Hepatol 2013; 58: 564-574.","DOI":"10.1016\/j.jhep.2012.10.005"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38. Kimmel PL, Cohen DJ, Abraham AA, Bodi I, Schwartz AM, Phillips TM: Upregulation of MHC class II, interferon-alpha and interferon-gamma receptor protein expression in HIV-associated nephropathy. Nephrol Dial Transplant 2003; 18: 285-292.","DOI":"10.1093\/ndt\/18.2.285"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39. Sanai T, Watanabe I, Hirano T, Nakayama M, Sakai H, Uesugi N, Masutani K, Katafuchi R, Hirakata H, Iida M: Successful steroid treatment in a patient with membranoproliferative glomerulonephritis associated with hepatitis C virus. Int Urol Nephrol 2009; 41: 179-183.","DOI":"10.1007\/s11255-007-9322-7"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40. Pandrangi S, Singh A, Wheeler DE, Rossi NF: Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis. Nat Clin Pract Nephrol 2008; 4: 393-397.","DOI":"10.1038\/ncpneph0823"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41. De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G: A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64: 843-853.","DOI":"10.1002\/art.34331"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42. Troxell ML, Shackleton DV, Raguram P, Houghton DC: Acute kidney injury with cryoglobulinemic peritubular neutrophilic capillaritis. Clin Nephrol 2011; 76: 159-164.","DOI":"10.5414\/CN106626"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43. Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N: Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 2003; 74: 1267-1271.","DOI":"10.1136\/jnnp.74.9.1267"},{"key":"43","unstructured":"44. Neri S, Pulvirenti D, Bertino G: Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b. Clin Drug Investig 2006; 26: 655-662."},{"key":"44","doi-asserted-by":"crossref","unstructured":"45. Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, Miller AH: Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun 2005; 19: 23-27.","DOI":"10.1016\/j.bbi.2004.05.001"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/82\/4\/82_193\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T22:32:56Z","timestamp":1567117976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/82\/4\/82_193\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.82.193","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}